Sherwin-Williams (NYSE:SHW - Free Report) had its price target reduced by UBS Group from $410.00 to $395.00 in a research note published on Wednesday,Benzinga reports. They currently have a buy rating on the specialty chemicals company's stock.
Several other research analysts also recently weighed in on the company. Barclays cut their price target on Sherwin-Williams from $385.00 to $355.00 and set an "equal weight" rating for the company in a research note on Tuesday, April 1st. Mizuho lowered their price target on Sherwin-Williams from $400.00 to $385.00 and set an "outperform" rating on the stock in a report on Wednesday. Loop Capital decreased their price objective on Sherwin-Williams from $395.00 to $380.00 and set a "buy" rating on the stock in a report on Wednesday. JPMorgan Chase & Co. decreased their price objective on Sherwin-Williams from $390.00 to $378.00 and set an "overweight" rating on the stock in a report on Wednesday. Finally, Wells Fargo & Company decreased their price objective on Sherwin-Williams from $420.00 to $400.00 and set an "overweight" rating on the stock in a report on Wednesday. One equities research analyst has rated the stock with a sell rating, six have given a hold rating, ten have assigned a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average target price of $383.33.
Check Out Our Latest Stock Analysis on SHW
Sherwin-Williams Trading Down 0.3%
Shares of Sherwin-Williams stock traded down $1.08 during midday trading on Wednesday, reaching $339.13. The company had a trading volume of 694,128 shares, compared to its average volume of 1,752,245. The stock has a fifty day moving average price of $348.62 and a 200 day moving average price of $348.06. The company has a debt-to-equity ratio of 1.78, a current ratio of 0.78 and a quick ratio of 0.45. The firm has a market cap of $84.99 billion, a PE ratio of 33.67, a P/E/G ratio of 3.25 and a beta of 1.18. Sherwin-Williams has a fifty-two week low of $308.84 and a fifty-two week high of $400.42.
Sherwin-Williams (NYSE:SHW - Get Free Report) last issued its earnings results on Tuesday, July 22nd. The specialty chemicals company reported $3.38 earnings per share for the quarter, missing analysts' consensus estimates of $3.76 by ($0.38). Sherwin-Williams had a return on equity of 66.91% and a net margin of 11.03%. The firm had revenue of $6.31 billion for the quarter, compared to analyst estimates of $6.31 billion. During the same period in the previous year, the company earned $3.70 earnings per share. Sherwin-Williams's revenue for the quarter was up .6% compared to the same quarter last year. On average, equities analysts anticipate that Sherwin-Williams will post 12 earnings per share for the current year.
Sherwin-Williams Dividend Announcement
The firm also recently announced a quarterly dividend, which will be paid on Friday, September 5th. Stockholders of record on Friday, August 15th will be paid a dividend of $0.79 per share. The ex-dividend date is Friday, August 15th. This represents a $3.16 annualized dividend and a dividend yield of 0.93%. Sherwin-Williams's dividend payout ratio (DPR) is presently 31.35%.
Institutional Investors Weigh In On Sherwin-Williams
Several hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Park Square Financial Group LLC bought a new position in Sherwin-Williams in the fourth quarter valued at about $27,000. Perkins Coie Trust Co purchased a new stake in shares of Sherwin-Williams during the first quarter worth about $27,000. Valley National Advisers Inc. grew its position in shares of Sherwin-Williams by 68.0% during the second quarter. Valley National Advisers Inc. now owns 84 shares of the specialty chemicals company's stock worth $28,000 after purchasing an additional 34 shares in the last quarter. Synergy Investment Management LLC grew its holdings in Sherwin-Williams by 583.3% during the 1st quarter. Synergy Investment Management LLC now owns 82 shares of the specialty chemicals company's stock valued at $29,000 after buying an additional 70 shares in the last quarter. Finally, Barnes Dennig Private Wealth Management LLC purchased a new position in Sherwin-Williams during the 1st quarter valued at approximately $30,000. 77.67% of the stock is owned by hedge funds and other institutional investors.
About Sherwin-Williams
(
Get Free Report)
The Sherwin-Williams Company engages in the development, manufacture, distribution, and sale of paints, coating, and related products to professional, industrial, commercial, and retail customers. It operates through three segments: Paint Stores Group, Consumer Brands Group, and Performance Coatings Group.
Featured Articles

Before you consider Sherwin-Williams, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sherwin-Williams wasn't on the list.
While Sherwin-Williams currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.